WHO ICTRP trial
A study to compare survival with Oral TKI against Oral TKI and intravenous…
CTRI/2016/08/007149 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2016/08/007149 |
|---|---|
| Public title | A study to compare survival with Oral TKI against Oral TKI and intravenous chemotherapy in advanced lung cancer patients |
| Scientific title | A randomized study to compare gefitinib vs chemotherapy with gefitinib in EGFR mutation positive Non-Small cell lung cancer in palliative setting. |
| Primary sponsor | Tata Memorial Centre |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: null- Patients who have EGFR mutation positive Non small Cell lung cancer |
| Interventions | Intervention1: Chemotherapy With Gefitinib: Chemotherapy with Pemetrexed 500mg/m2 + carboplatin AUC 5 x 3weekly for 4 cycles followed by only pemetrexed with Gefitinib 250 mg OD till progression (Arm B) Control Intervention1: Gefitinib… |
| Registration date | May 8, 2016 |
| Target size | 350 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: